My watch list  

3,591 Current news from the ressort products


You can refine your search further. Select from the filter options on the left to narrow down your results.

Marinomed receives funding to research SARS-CoV-2 therapy


Marinomed Biotech AG receives funding from the Austrian Research Promotion Agency (FFG) for the development of a SARS-CoV-2 therapy based on Carragelose®. The aim of the project is to clinically test an inhalation solution as an acute treatment for viral pneumonia caused by SARS-CoV-2 or other ...


image description
Precise diagnostics with artificial intelligence

BIH Digital Health Accelerator guides Aignostics GmbH through its spin-off


The usual way to determine if a suspicious lump is cancerous involves microscopic examination in a pathology laboratory. To ease the workload of pathologists who face a rising number of cancer cases and increasingly finer molecular details and to enable tailored treatments, scientists at the ...


Sanofi and Luminostics to join forces on developing breakthrough COVID-19 smartphone-based self-testing solution


Sanofi and Luminostics have signed an agreement to evaluate a collaboration on a unique self-testing solution for COVID-19, using Luminostics’ technology, and further adding to Sanofi’s ongoing efforts to fight the COVID-19 pandemic on multiple fronts.Luminostics would contribute its proprietary ...


image description
Merck Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing

Joint team reduced process development time to two months from a year


Merck and The Jenner Institute announced that the Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19. With patients enrolled for clinical trials for this vaccine, rapid development of the large-scale manufacturing process is a ...


image description
Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19

Companies have set up a Joint Task Force


Sanofi and GSK announce that they have signed a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies, to help address the ongoing pandemic. Sanofi will contribute its S-protein COVID-19 antigen, which is based on recombinant DNA ...


image description
Pfizer and BioNTech to Accelerate Global COVID-19 Vaccine Development


BioNTech SE and Pfizer Inc. disclosed additional details of their collaboration to advance candidates from BioNTech’s mRNA vaccine program, previously announced on March 17, 2020. The collaboration aims to rapidly advance multiple COVID-19 vaccine candidates into human clinical testing based on ...


image description
Antiviral treatment for textiles


An ETH spin-​off has developed a new treatment for textiles that reduces viral infectivity on treated surfaces. The technology can be used for face masks and other textile products. Recently, the ETH spin-​off HeiQ Materials presented an innovative antiviral and antibacterial treatment for ...


image description
Remote medical image diagnosis

Startup provides app free of charge during corona crisis


The current crises caused by the fast spread of covid-19 is forcing clinics and its medical staff to take actions that otherwise would require months or years: Home office and the provision of mobile software solutions. mbits, a spin-off of the German Cancer Research Center (DKFZ), has ...


image description
Neurimmune and Ethris plan to develop inhaled mRNA-based antibody therapy for the treatment of Covid-19

Companies expect to initiate clinical testing in 2020


Neurimmune AG and Ethris GmbH announced an exclusive partnership to develop mRNA-encoded, neutralizing anti-SARS-CoV-2 antibodies administered by inhalation for the treatment of Covid-19. The collaboration brings together Neurimmune’s expertise in developing human antibodies based on ...


image description
Bosch develops rapid test for COVID-19

Test results enable differential diagnosis in under 2.5 hours


The coronavirus SARS-CoV-2 is posing major challenges for healthcare systems and medical institutions worldwide. An ability to rapidly diagnose the virus is of invaluable help in curbing its exponential spread in many countries. Bosch’s new, fully automated rapid test for COVID-19 can help ...


Page 2 From 360
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE